疾病控制和预防中心的主任罗谢尔·瓦伦斯基博士即将离开该机构，总裁乔·拜登宣布。
将于6月底离职的瓦伦斯基在一份声明中说，“新冠肺炎公共卫生紧急状态的结束标志着我们国家、公共卫生以及我担任疾病预防控制中心主任期间的巨大转变。”
她说她的目标是“将疫情的黑暗日子抛在身后，将CDC和公共卫生带向一个更好、更值得信任的地方。”
“在这个过程中，我们拯救和改善了生命，保护国家和世界免受100多年来最大的传染病威胁，”瓦伦斯基说。
拜登在一份声明中说:“她诚实正直地领导着一个复杂的组织，站在一代人一次的疫情的最前线。”。“瓦伦斯基博士让疾病预防控制中心成为一个更强大的机构，能够更好地应对健康威胁和保护美国人。”
“我们都从她的服务和对公共卫生的奉献中受益，我祝愿她在下一章中一切顺利，”拜登补充道。
拜登选择瓦伦斯基在2020年12月领导疾病预防控制中心，取代罗伯特·雷德菲尔德博士，后者在前总统唐纳德·特朗普政府的大部分时间里担任主任。
据报道，在成为主任之前，瓦伦斯基是马萨诸塞州总医院传染病部门的负责人，也是哈佛医学院的医学教授医院网站。
她在20世纪80年代艾滋病毒/艾滋病流行的高峰期开始了她的职业生涯，并在南非改善艾滋病毒筛查和护理，还担任了艾滋病研究咨询委员会办公室主席传记疾控中心网站上写着。
瓦伦斯基于2021年1月担任主任，当时公共卫生专家表示，由于疫情早期的失误和政治干预，该机构缺乏公众信任。
虽然她领导疾控中心成功推出了新冠肺炎疫苗，并批准了更新的加强剂，但她的任期并非没有缺点，包括她在去年夏天进行的一次审查中承认的那些缺点。
“75年来，疾病预防控制中心和公共卫生一直在为新冠肺炎做准备，在我们的重要时刻，我们的表现没有可靠地达到预期，”瓦伦斯基在八月说在2022年8月给员工的一段内部视频中，当时美国广播公司新闻(ABC News)看到了这段视频。“坦率地说，我们要对一些相当戏剧性的、相当公开的错误负责。从测试到数据，再到通信。”
“我们所有人都被要求展望未来，建立一个更强大的疾病预防控制中心来应对未来。这是我们的分水岭时刻，”她补充道。
2021年12月8日，美国疾病预防控制中心主任罗谢尔·沃伦斯基博士给美国广播公司新闻首席医疗记者詹妮弗·阿什顿博士提供了一个进入亚特兰大疾病预防控制中心紧急行动中心的难得机会
美国广播公司马特·米勒
它出现在内部审查瓦伦斯基在2022年4月下令批评该机构在新冠肺炎疫情期间的表现。
根据美国广播公司新闻当时获得的调查结果，该审查发现，“疾病控制和预防中心发布用于决策的数据和科学需要太长时间”，其指导“令人困惑和不知所措”，并且在新冠肺炎反应期间机构工作人员的更替“给合作伙伴造成了差距和其他挑战”。
作为回应，瓦伦斯基下令进行“雄心勃勃”的改革，包括建立一个向瓦伦斯基报告的新执行委员会，以“确定机构的优先事项，跟踪进展，并调整预算决定，侧重于公共卫生影响。”
Rochelle Walensky, CDC director, leaving agency, Biden says
Dr. Rochelle Walensky, the director of the Centers for Disease Control and Prevention, is leaving the agency, PresidentJoe Bidenannounced.
Walensky, who will leave at the end of June, said in a statement, "The end of the COVID-19 public health emergency marks a tremendous transition for our country, for public health, and in my tenure as CDC Director."
She said her goal was "leaving behind the dark days of the pandemic and moving CDC -- and public health -- forward into a much better and more trusted place."
"In the process, we saved and improved lives and protected the country and the world from the greatest infectious disease threat we have seen in over 100 years," Walensky said.
"She led a complex organization on the frontlines of a once-in-a-generation pandemic with honesty and integrity," Biden said in a statement. "Dr. Walensky leaves CDC a stronger institution, better positioned to confront health threats and protect Americans."
"We have all benefited from her service and dedication to public health, and I wish her the best in her next chapter," Biden added.
Biden selected Walensky to lead the CDC in December 2020, replacing Dr. Robert Redfield, who was the director throughout the majority of former President Donald Trump’s administration.
Prior to becoming director, Walensky was the chief of the division of infectious diseases at Massachusetts General Hospital and a professor of medicine at Harvard Medical School, according to thehospital’s website.
She began her career during the height of the HIV/AIDS epidemic in the 1980s and spent time in South Africa improving HIV screening and care and also spent tie as chair of the Office of AIDS Research Advisory Council, herbiographyon the CDC website states.
Walensky took the helm as director in January 2021 during a time when public health experts said the agency was suffering from a lack of public trust, due to missteps made during the early days of the pandemic and political interference.
While she led the CDC during the successful rollout of the COVID-19 vaccine, and the approval of updated boosters, her tenure was not without faults, including those she acknowledged in a review conducted last summer.
"For 75 years, CDC and public health have been preparing for COVID-19, and in our big moment, our performance did not reliably meet expectations,"Walensky said in Augustin an internal video to employees in August 2022, which was viewed by ABC News at the time. "To be frank, we are responsible for some pretty dramatic, pretty public mistakes. From testing, to data, to communications."
"All of us collectively are being asked to look to the future and build a stronger CDC to tackle what lies ahead. This is our watershed moment," she added.
It comes after aninternal review, which Walensky ordered in April 2022, criticized the agency’s performance during the COVID-19 pandemic.
The review found that it "takes too long for CDC to publish its data and science for decision making," that its guidance is "confusing and overwhelming" and that agency staff turnover during the COVID-19 response "created gaps and other challenges for partners," according to findings obtained by ABC News at the time.
In response, Walensky ordered an “ambitious” overhaul, including creating a new executive council reporting to Walensky to "determine agency priorities, track progress, and align budget decisions, with a bias toward public health impact."
